Table 1

Baseline laboratory parameters

Investigations and reference rangesValues
Full blood count
 White blood cells (x109/L (4–11))18
 Neutrophil (x109/L (7.5–11))15.3
 Lymphocytes (x109/L (1.5–4.0))1.9
 Haemoglobin (g/dL (11-15))167
 PCV (L/L (0.4–054))0.469
 Platelet counts (x109/L (150 000–450 000))340
Renal functions
 Serum sodium (mmol/L (135–145))139
 Serum potassium (mmol/L (3.5–5.1))4.2
 Serum creatinine (μmol/L (44–97))61
 Blood urea (mmol/L (2.5 to 7.1))4.6
 EGFR mL/min/1.73 m2>90
Inflammatory markers
 C reactive protein (<5 mg/dL)5
Coagulation screen
 aPTT (23.0–31.0 s)21.5
 PT (9.5–13.5 s)12
 TT (13.7–19 s)15
 Fibrinogen (1.8–3.5 g/L)3.3
Liver functions
 Bilirubin (0–21 umol/L)10
 Alanine transaminase (<41 IU/L)39
 Albumin (35–50 g/L)49
 Alkaline phosphate (30–130 U/L)105
 Total protein (60–80 g/L)70
 Amylase (28–100 IU/L)62
Thrombotic screening
 Anticardiolipin Ab IgG (GPL U/mL (<10))0.8
 Anticardiolipin Ab IgM (MPL U/mL (<10))2.7
 B 2 glycoprotein IgG Ab (u/mL (<10))<1
 B 2 glycoprotein IgM Ab (u/mL (<10))<3
 D –dimer ((ug/L) <500)3026
 Fibrinogen (g/L (1.8–3.5))3.3
 JAK2 V617F MutationNegative
Viral screening
 Hepatitis B surface antigenNegative
 Hepatitis C antibodiesNegative
 Anti HIV ½Negative
 SARS-CoV-2 RT polymeraseNegative
Lipid profile
 Cholesterol (<5.2 mmol/L)4.9
 Triglycerides (0.8–2.3 mmol/L)1.9
 HDL (0.9–1.6 mmol/L)0.8
 Non-HDL4.1
  • aPTT, Activated partial thromboplastin time; EGFR, Estimated glomerular filtration rate; GPL, IgG Phospholipid Units; HDL, High-density lipoproteins; MPL, IgM Phospholipid Units; PCV, Packed cell volume; PT, Prothrombin time; TT, Thrombin time.